FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

13230501000001103: Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 28-Nov 2018. Module: SNOMED CT United Kingdom drug extension module

    Descriptions:

    Id Description Lang Type Status Case? Module
    109736601000001115 Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
    109736701000001113 Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Is a Product containing betamethasone and salicylic acid false Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Is a Virtual medicinal product false Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application VMP prescribing status (attribute) VMP valid as a prescribable product false Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Betamethasone false Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has active ingredient Betamethasone false Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has dispensed dose form Basic dose form with liquid state of matter false Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has specific active ingredient Salicylic acid false Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Has specific active ingredient Betamethasone dipropionate false Inferred relationship Existential restriction modifier
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Diprosalic 0.05%/2% scalp application (Organon Pharma (UK) Ltd) Is a False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (PI) (Waymade Ltd) Is a False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Dowelhurst Ltd) Is a False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Doncaster Pharmaceuticals Ltd) Is a False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Sigma Pharmaceuticals Plc) Is a False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Lexon (UK) Ltd) Is a False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Mawdsley-Brooks & Company Ltd) Is a False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
    Diprosalic scalp application (Necessity Supplies Ltd) Is a False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
    Salicylic acid 2% / Betamethasone dipropionate 0.05% scalp application 100 ml Has VMP False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier
    Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application 60 ml Has VMP False Betamethasone dipropionate 0.05% / Salicylic acid 2% scalp application Inferred relationship Existential restriction modifier

    This concept is not in any reference sets

    Back to Start